1
|
Zou T, Sugimoto K, Zhao Y, Li B, Zhou X, Peng C. Zhi-zi-chi decoction mitigates depression by enhancing lncRNA Six3os1 expression and promoting histone H3K4 methylation at the BDNF promoter. J Cell Mol Med 2024; 28:e18365. [PMID: 38818577 PMCID: PMC11140235 DOI: 10.1111/jcmm.18365] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2023] [Revised: 03/18/2024] [Accepted: 04/16/2024] [Indexed: 06/01/2024] Open
Abstract
Traditional Chinese medicine, particularly Zhi-zi-chi decoction (ZZCD), is gaining recognition as a potential treatment for depression. This study aimed to uncover the molecular mechanisms behind ZZCD's antidepressant effects, focusing on lncRNA Six3os1 and histone H3K4 methylation at the BDNF promoter. Network pharmacology and in vivo experiments were conducted to identify ZZCD targets and evaluate its impact on depression-related behaviours and neuron injury. The role of Six3os1 in recruiting KMT2A to the BDNF promoter and its effects on oxidative stress and neuron injury were investigated. ZZCD reduced depression-like behaviours and neuron injury in mice subjected to chronic stress. It upregulated Six3os1, which facilitated KMT2A recruitment to the BDNF promoter, leading to increased histone H3K4 methylation and enhanced BDNF expression. ZZCD also inhibited CORT-induced neuron injury, inflammatory response and oxidative stress in vitro. ZZCD's antidepressant properties involve Six3os1 upregulation, which exerts neuroprotective effects by inhibiting oxidative stress and neuron injury, thereby alleviating depressive symptoms. Targeting Six3os1 upregulation may offer a potential therapeutic intervention for depression.
Collapse
Affiliation(s)
- Tianyu Zou
- Department of EncephalopathyShenzhen Luohu District Hospital of Traditional Chinese MedicineShenzhenChina
- Department of EncephalopathyShenzhen Hospital of Shanghai University of Traditional Chinese MedicineShenzhenChina
| | - Kazuo Sugimoto
- Department of Neurology, Dongzhimen HospitalBeijing University of Chinese MedicineBeijingChina
- Institute for Brain DisordersBeijing University of Chinese MedicineBeijingChina
| | - Yu Zhao
- Department of Acupuncture, First Affiliated HospitalHeilongjiang University of Chinese MedicineHarbinChina
| | - Baitao Li
- Department of Acupuncture, First Affiliated HospitalHeilongjiang University of Chinese MedicineHarbinChina
| | - Xiaomao Zhou
- Department of EncephalopathyShenzhen Luohu District Hospital of Traditional Chinese MedicineShenzhenChina
- Department of EncephalopathyShenzhen Hospital of Shanghai University of Traditional Chinese MedicineShenzhenChina
| | - Cheng Peng
- Department of EncephalopathyShenzhen Luohu District Hospital of Traditional Chinese MedicineShenzhenChina
- Department of EncephalopathyShenzhen Hospital of Shanghai University of Traditional Chinese MedicineShenzhenChina
| |
Collapse
|
2
|
Zhang D, Ma J, Zheng X, Zhang Z, Lian X, Zhao X, Zhao X. Fabrication of a bioconjugated dual-functional SERS probe for facile compound screening and detection. Biosens Bioelectron 2023; 234:115369. [PMID: 37163878 DOI: 10.1016/j.bios.2023.115369] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2022] [Revised: 04/14/2023] [Accepted: 04/30/2023] [Indexed: 05/12/2023]
Abstract
Surface-enhanced Raman spectroscopy (SERS) is an ultrasensitive technique for both detection and structural characterizations. To further exploit these advantages, we designed and fabricated a dual-functional SERS probe for specific capture and fast detection of small molecule ligands binding to target protein from a mixture of compounds such as extracts of natural products. As a proof of concept, we synthesized SiO2@Ag nanoclusters that are coated with 6-chlorohexanoic acid for covalent immobilization of serotonin transporter (5-HTT) fused with a Halo-tag through enzyme-substrate recognition. As such, we fabricated a bioconjugated SERS probe, and the synthesis, coating, protein immobilization, and affinity-based ligand binding have been characterized and verified by transmission electron microscope (TEM), X-ray photoelectron spectroscopy (XPS), and elemental mapping. By applying this probe to analyze Gardenia jasminoides extract, we have successfully identified crocin I as a compound binding to 5-HTT, which was further proved by using mass spectrometry (MS) and nuclear magnetic resonance (NMR). Taken together, we have developed a novel SERS probe by integrating the inherent strength of SERS in molecular analysis with an extended functionality of affinity-guided molecular capture, which has demonstrated the potential in drug screening of challenging systems.
Collapse
Affiliation(s)
- Dandan Zhang
- College of Life Sciences, Northwest University, Xi'an, 710069, China
| | - Jing Ma
- College of Life Sciences, Northwest University, Xi'an, 710069, China
| | - Xinxin Zheng
- College of Life Sciences, Northwest University, Xi'an, 710069, China
| | - Zilong Zhang
- College of Life Sciences, Northwest University, Xi'an, 710069, China
| | - Xiaojuan Lian
- College of Life Sciences, Northwest University, Xi'an, 710069, China
| | - Xue Zhao
- College of Life Sciences, Northwest University, Xi'an, 710069, China
| | - Xinfeng Zhao
- College of Life Sciences, Northwest University, Xi'an, 710069, China.
| |
Collapse
|
3
|
Zhang Y, Fang YC, Cui LX, Jiang YT, Luo YS, Zhang W, Yu DX, Wen J, Zhou TT. Zhi-Zi-Chi Decoction Reverses Depressive Behaviors in CUMS Rats by Reducing Oxidative Stress Injury Via Regulating GSH/GSSG Pathway. Front Pharmacol 2022; 13:887890. [PMID: 35462900 PMCID: PMC9021728 DOI: 10.3389/fphar.2022.887890] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2022] [Accepted: 03/21/2022] [Indexed: 12/27/2022] Open
Abstract
Depression is one of the main diseases that lead to disability and loss of ability to work. As a traditional Chinese medicine, Zhi-zi-chi decoction is utilized to regulate and improve depression. However, the research on the antidepressant mechanism and efficacy material basis of Zhi-zi-chi decoction has not been reported yet. Our previous research has found that Zhi-Zi-chi decoction can reduce glutamate-induced oxidative stress damage to PC 12 cells, which can exert a neuroprotective effect, and the antidepressant effect of Zhi-Zi-chi decoction was verified in CUMS rat models. In this study, the animal model of depression was established by chronic unpredictable mild stimulation combined with feeding alone. The brain metabolic profile of depressed rats was analyzed by the method of metabolomics based on ultra-performance liquid chromatography-quadrupole/time-of-flight mass. 26 differential metabolites and six metabolic pathways related to the antidepressant of Zhi-zi-chi decoction were screened and analyzed. The targeted metabolism of the glutathione metabolic pathway was analyzed. At the same time, the levels of reactive oxygen species, superoxide dismutase, glutathione reductase, glutathione peroxidase in the brain of depressed rats were measured. Combined with our previous study, the antioxidant effect of the glutathione pathway in the antidepressant effect of Zhi-zi-chi decoction was verified from the cellular and animal levels respectively. These results indicated that Zhi-zi-chi decoction exerted a potential antidepressive effect associated with reversing the imbalance of glutathione and oxidative stress in the brain of depressed rats.
Collapse
Affiliation(s)
- Yin Zhang
- School of Pharmacy, Second Military Medical University, Shanghai, China
- Shanghai Key Laboratory for Pharmaceutical Metabolite Research, School of Pharmacy, Second Military Medical University, Shanghai, China
- Chengdu Institute for Drug Control, Chengdu, China
| | - Yi-Chao Fang
- School of Pharmacy, Second Military Medical University, Shanghai, China
- Shanghai Key Laboratory for Pharmaceutical Metabolite Research, School of Pharmacy, Second Military Medical University, Shanghai, China
| | - Li-Xun Cui
- School of Pharmacy, Second Military Medical University, Shanghai, China
- Shanghai Key Laboratory for Pharmaceutical Metabolite Research, School of Pharmacy, Second Military Medical University, Shanghai, China
| | - Yue-Tong Jiang
- School of Pharmacy, Second Military Medical University, Shanghai, China
- Shanghai Key Laboratory for Pharmaceutical Metabolite Research, School of Pharmacy, Second Military Medical University, Shanghai, China
| | - Yu-Sha Luo
- School of Pharmacy, Second Military Medical University, Shanghai, China
- Shanghai Key Laboratory for Pharmaceutical Metabolite Research, School of Pharmacy, Second Military Medical University, Shanghai, China
| | - Wen Zhang
- School of Pharmacy, Second Military Medical University, Shanghai, China
- Shanghai Key Laboratory for Pharmaceutical Metabolite Research, School of Pharmacy, Second Military Medical University, Shanghai, China
| | - De-Xun Yu
- School of Pharmacy, Second Military Medical University, Shanghai, China
- Shanghai Key Laboratory for Pharmaceutical Metabolite Research, School of Pharmacy, Second Military Medical University, Shanghai, China
| | - Jun Wen
- School of Pharmacy, Second Military Medical University, Shanghai, China
- Shanghai Key Laboratory for Pharmaceutical Metabolite Research, School of Pharmacy, Second Military Medical University, Shanghai, China
- *Correspondence: Jun Wen, ; Ting-Ting Zhou,
| | - Ting-Ting Zhou
- School of Pharmacy, Second Military Medical University, Shanghai, China
- Shanghai Key Laboratory for Pharmaceutical Metabolite Research, School of Pharmacy, Second Military Medical University, Shanghai, China
- *Correspondence: Jun Wen, ; Ting-Ting Zhou,
| |
Collapse
|